Researchers report that the breast cancer drug Herceptin should be given at the same time as chemotherapy, not after chemotherapy is concluded.

Packaging lung cancer drugs in inhalable bubbles could avoid their nasty side effects, allowing bigger doses to be given safely

Chemo-metabolic processes such as redox remodeling and amino acid availability act as immunity rheostats, revealing a new mechanism regulating intercellular cross-talk between dendritic cells, regulatory T lymphocytes and effector T lymphocytes.

Packaging lung cancer drugs in inhalable bubbles could avoid their nasty side effects, allowing bigger doses to be given safely

Men wondering about the long-term side effects of chemotherapy for testicular cancer may now have a road map defining likely outcomes. Source: Reuters Health

Related MedlinePlus Topics: Cancer Chemotherapy, Radiation Therapy, Testicular Cancer

Although patients may prefer an oral drug to intravenous chemotherapy, a study in elderly women with early-stage breast cancer found the results were inferior. Medscape Medical News

American researchers have found that a new chemotherapy combination comprising gemcitabine and cisplatin shows promise in endometrial cancer treatment. The study, conducted by scientists from The University of Texas M. D. Anderson Cancer Center, showe

When cancer treatment delivers a knockout punch to cognitive abilities, patients often face major challenges trying to get their lives back on track.

When cancer treatment delivers a knockout punch to cognitive abilities, patients often face major challenges trying to get their lives back on track.

WEDNESDAY, Nov. 25 -- Neurological side effects are among the potential problems faced by long-term survivors of testicular cancer who were treated with cisplatin-based chemotherapy, a new study has found.
The study included 1,409 Norwegian men...

CHICAGO --- Think of a protective fence that blocks the neighbor's dog from charging into your backyard. The body, too, has fences -- physical and biochemical barriers that keep cells in their place.

A new chemotherapy cocktail cuts the spread of breast cancer by half and is the first drug to attack metastasizing breast cancer. The disease becomes fatal when it travels outside the mammary ducts, enters the bloodstream and spreads to the bones, liver or brain. Currently, there are only drugs that try to stem the uncontrolled division of cancer cells within the ducts.

HealthDay - WEDNESDAY, Oct. 14 (HealthDay News) -- Among women with locally
advanced breast cancer who undergo the same class of chemotherapy, race
doesn't affect the odds of having no sign of disease at surgery, a new
study finds.

(Purdue University) Tiny nanoprobes have shown to be effective in delivering cancer drugs more directly to tumor cells -- mitigating the damage to nearby healthy cells -- and Purdue University research has shown that the nanoprobes are getting the drugs to right cellular compartments.

Tiny nanoprobes have shown to be effective in delivering cancer drugs more directly to tumor cells - mitigating the damage to nearby healthy cells - and Purdue University research has shown that the nanoprobes are getting the drugs to right cellular compartments.
read more

Tiny nanoprobes have shown to be effective in delivering cancer drugs more directly to tumor cells -- mitigating the damage to nearby healthy cells -- and new research has shown that the nanoprobes are getting the drugs to right cellular compartments.

Tiny nanoprobes have shown to be effective in delivering cancer drugs more directly to tumor cells -- mitigating the damage to nearby healthy cells -- and new research has shown that the nanoprobes are getting the drugs to right cellular compartments.

(Purdue University) Tiny nanoprobes have shown to be effective in delivering cancer drugs more directly to tumor cells -- mitigating the damage to nearby healthy cells -- and Purdue University research has shown that the nanoprobes are getting the drugs to right cellular compartments.

(Jackson Laboratory) With a new two-year, $1 million grant from the National Cancer Institute, Jackson Laboratory Professor Gary Churchill is launching a radical new approach to testing three chemotherapeutic drugs for potential toxic effects, using an outbred mouse population that approximates the genetic diversity observed in human populations.

(Jackson Laboratory) With a new two-year, $1 million grant from the National Cancer Institute, Jackson Laboratory Professor Gary Churchill is launching a radical new approach to testing three chemotherapeutic drugs for potential toxic effects, using an outbred mouse population that approximates the genetic diversity observed in human populations.

(ECCO-the European CanCer Organisation) The presence of a protein called PARP in tumors can help predict their response to chemotherapy, German researchers will tell the European Breast Cancer Conference on Friday, March 26. They have found that PARP expression exists across all breast cancer subtypes, and that these tumors are highly sensitive to chemotherapy. PARP positive tumors could become a new entity in breast cancer, and the researchers believe that they may be on the verge of a major change in the way breast cancer is treated.